Koen Van Besien to Thalidomide
This is a "connection" page, showing publications Koen Van Besien has written about Thalidomide.
Connection Strength
0.439
-
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. Lancet Haematol. 2017 Sep; 4(9):e431-e442.
Score: 0.142
-
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma. Biol Blood Marrow Transplant. 2017 Jun; 23(6):930-937.
Score: 0.138
-
Lenalidomide after stem-cell transplantation for multiple myeloma. N Engl J Med. 2012 May 10; 366(19):1770-81.
Score: 0.099
-
Arterial thrombosis in four patients treated with thalidomide. Leuk Lymphoma. 2005 Feb; 46(2):239-42.
Score: 0.060